Form 4: UNH Director Timothy Flynn Receives Stock Grant

UnitedHealth Group Director Timothy P. Flynn acquired 285 deferred stock units as part of his regular quarterly compensation, increasing his direct beneficial ownership.

Summary

• Timothy Patrick Flynn, a Director of UnitedHealth Group Inc. (UNH), acquired 285 shares of common stock.
• The transaction occurred on January 2, 2026, and was reported on January 6, 2026.
• These shares represent deferred stock units granted as regular quarterly compensation for his service as a director.
• The deferred stock units are immediately vested but must be retained by the director until the completion of his service on the Board.
• Following this transaction, Mr. Flynn directly beneficially owns 10,160 shares and indirectly owns 6,033 shares through a trust.
• The transaction price for these units was $0, typical for compensation grants.

Sentiment

Score: 6

Explanation: This Form 4 reports a routine compensation grant to a director, which is a neutral event. The grant of deferred stock units, which must be retained until the director's service completion, is a positive for aligning director and shareholder interests.

Positives

• The grant of deferred stock units aligns the director's interests with those of shareholders, as the value of his compensation is tied to the company's stock performance.
• The immediate vesting of the units, combined with the retention requirement until board service completion, ensures long-term commitment from the director.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance. It solely reports an insider transaction.

Industry Context

The grant of deferred stock units as compensation to directors is a common practice across publicly traded companies, particularly in the healthcare and insurance sectors, to attract and retain experienced board members and align their interests with long-term shareholder value.

Comparison to Industry Standards

• The practice of compensating directors with equity, such as deferred stock units, is a standard corporate governance practice.
• Companies like Johnson & Johnson, CVS Health, and Elevance Health (formerly Anthem) also utilize similar equity-based compensation structures for their non-employee directors to foster alignment with shareholder interests and promote long-term decision-making.
• The specific number of units granted would typically be benchmarked against peer companies based on factors like company size, industry, and director responsibilities.

Corporate Governance

Related Party Transactions

• The transaction involves compensation to a director, which is a form of related party transaction, but it is a standard and disclosed practice for director remuneration.

Stakeholder Impact

• Shareholders: Minor positive impact due to increased alignment of director's interests with long-term shareholder value through equity compensation and retention requirements.

Next Steps

• The director is required to retain the deferred stock units until the completion of his service on the Board.

Key Dates

Keywords

UnitedHealth Group, UNH, Timothy Flynn, Director Compensation, Deferred Stock Units, Insider Transaction, Form 4, Stock Grant, Beneficial Ownership